Allen Hicks | Washington, D.C. | Hogan Lovells

Allen Hicks
Hicks Allen
  • Overview
  • Experience
  • Credentials
  • Insights and events

Allen Hicks is a trusted advisor that helps his clients execute complex strategic transactions, raise and invest capital, and navigate the securities laws. He draws upon a diverse skill set developed through two decades of experience with a broad range of companies and industries to provide practical advice and insights for his clients.

Allen has represented public and privately held companies on strategic domestic and cross-border transactions, such as mergers and acquisitions (M&A), stock and asset purchases, divestitures, investments, tender offers and restructurings/reorganizations. He also regularly advises public companies on Securities and Exchange Commission (SEC) reporting and disclosure obligations, New York Stock Exchange (NYSE) and NASDAQ listing requirements, corporate governance, board and shareholder matters, and capital markets offerings of equity and debt.

Over his career, he has represented clients in the U.S. and internationally across various industry sectors, including life sciences and health care, aerospace and defense, government, diversified industrials, financial services, insurance, hotel and lodging, real estate investment trusts (REITs), and technology. His clients range from large, global corporations to middle-market and emerging growth companies and investors to nonprofit organizations.

Before joining the firm, Allen served as Chief Counsel to U.S. Senate Majority Leader William H. Frist. Passionate about the firm's commitment to Pro Bono and Citizenship, Allen also is active in supporting anti-sexual violence organization RAINN and helping find a cure for type 1 diabetes through the Juvenile Diabetes Research Foundation (JDRF).

Representative experience

Represented Labcorp (NYSE: LH) in over US$5bn of acquisitions, including Genzyme Genetics, Monogram Biosciences,  Liposcience, Sequenom, Chiltern, Sciformix, Envigo and Personal Genome Diagnostics

Represented Labcorp (NYSE: LH) in complex legal entity rationalization, reorganization and rebranding initiatives involving more than 100 legal entities in more than 50 countries

Represented OptumInsight of UnitedHealth Group (NYSE: UNH) in its US$1.3bn acquisition of the health care business of The Advisory Board and OptumRX in its US$300m acquisition of Diplomat Pharmacy

Represented General Electric (NYSE: GE) Capital in the US$9bn sale of its healthcare financial services business to Capital One

Represented Lockheed Martin Corporation (NYSE: LMT) in multiple strategic acquisitions and more than US$11bn in debt securities offerings

Represented REIT American Homes 4 Rent (NYSE: AMH) in more than US$1.3bn of common and preferred stock offerings, including a US$880m IPO

Represented Dun & Bradstreet Corporation (NYSE: DNB) in its acquisitions of technology companies NetProspex and Avention

Represented a nonprofit U.S. foundation in a reorganization of its holdings in a hotel and residential real estate resort development in Costa Ric


  • J.D., University of Tennessee, 2000
  • M.B.A., University of Tennessee, 2000
  • A.B., Stanford University, 1993
Bar admissions and qualifications
  • District of Columbia
  • Georgia
  • Member, Business Law Section, American Bar Association


Capital Markets, Notable Practitioner


M&A, Notable Practitioner